According to Theravance Biopharma 's latest financial reports the company's current earnings are NZ$64.38 Million. , an increase over its 2023 earnings that were of -NZ$86.3 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2024 | -NZ$78.15 Million | -9.45% |
2023 | -NZ$86.3 Million | -46.92% |
2022 | -NZ$0.17 Billion | -57.85% |
2021 | -NZ$0.39 Billion | -23.16% |
2020 | -NZ$0.51 Billion | 18.56% |
2019 | -NZ$0.43 Billion | 6.9% |
2018 | -NZ$0.4 Billion | -16.79% |
2017 | -NZ$0.48 Billion | 50.48% |
2016 | -NZ$0.32 Billion | -0.39% |
2015 | -NZ$0.32 Billion | -21.42% |
2014 | -NZ$0.41 Billion | 47.6% |
2013 | -NZ$0.28 Billion |